Knee osteoarthritis management with ESCEO guidelines: The importance of a multimodal approach

01 Feb 2023
Knee osteoarthritis management
with ESCEO guidelines:
The importance of a multimodal approach
At the Pain Masterclass Tour Symposium, held at Le Meridien Kuala Lumpur, Prof Dr Reginster discussed the ESCEO guidelines for the management of knee osteoarthritis (OA) in improving the quality of life of individuals suffering from this disease, and presented information and evidence affirming the efficacy of the novel symptomatic slow-acting drugs for OA(SYSADOAs), patented crystalline glucosamine sulfate (pCGS).
Sponsored as an educational program by Mylan Healthcare Sdn Bhd (a Viatris Company)

Related MIMS Drugs

Resources

MY-PFO-014latest

MY-PFO-014latest

MY-PFO-014latest

MY-PFO-014latest